Suzhou, May 21, 2026 – Pixel Wiser served as a co-host for the Post-AACR 2026 Recap,  held in Suzhou, bringing together leading oncology R&D experts from China and abroad to exchange insights on key challenges and innovative technical solutions in early-phase clinical research.

The conference featured a keynote speech by Dong Jing, Chief Operating Officer of Pixel Wiser, titled Oncology Clinical Imaging Endpoint: Insight from Early Stage to Global Stage. In his presentation, Mr. Dong highlighted a pervasive industry bottleneck: imaging data generated in early-phase trials often suffer severe fragmentation across dispersed investigational sites, compounded by inconsistent equipment and site‑specific workflows. Such fragmentation erodes data uniformity and integrity, slowing cross‑trial analysis and strategic clinical decision‑making.

To address this long‑standing pain point, Pixel Wiser introduced a standardized service framework built around centralized image collection and unified archival management. The system establishes a robust data infrastructure that delivers traceable, audit‑ready, GCP‑compliant imaging datasets. This approach strengthens the credibility of imaging‑derived endpoints and streamlines coordination for global multi‑center programs.

Beyond the scientific sessions, Pixel Wiser operated an exclusive exhibition booth showcasing its end‑to‑end service portfolio and proprietary technological breakthroughs in clinical imaging standardization. 

Looking ahead, Pixel Wiser will continue to deepen its expertise in imaging standardization and digital clinical innovation. The company remains committed to delivering more efficient, high‑precision imaging evaluation solutions to accelerate global novel drug R&D, supporting the high‑quality, standardized advancement of oncology clinical research worldwide.